Complementary exams in the diagnosis of American tegumentary leishmaniasis

Ciro Martins Gomes, Natália Aparecida de Paula, Orlando Oliveira de Morais, Killarney Ataíde Soares, Ana Maria Roselino, Raimunda Nonata Ribeiro Sampaio, Ciro Martins Gomes, Natália Aparecida de Paula, Orlando Oliveira de Morais, Killarney Ataíde Soares, Ana Maria Roselino, Raimunda Nonata Ribeiro Sampaio

Abstract

The diagnosis of American Tegumentary Leishmaniasis is a difficult but essential task when considering the high toxicity profile of the drugs available. Since the discovery of its etiologic agent, numerous diagnostic tests have been developed. None of the tests available today can be considered as the gold standard, since they do not add enough accuracy for the disease detection. Good epidemiological and clinical knowledge of the disease are fundamental precepts of the dermatology practice and precede the rational use of existing diagnostic tests. In this article we aim, through extensive literature review, to recall fundamental concepts of any diagnostic test. Subsequently, based on this information, we will weave important comments about the characteristics of existing diagnostic tests, including immunological tests such as Montenegro's skin test, serology and detection of parasites by direct examination, culture or histopathology. Finally we will discuss the new technologies and options for the diagnosis of Cutaneous Leishmaniasis. The molecular biology technique is considered a promising tool, promoting the rapid identification of the species involved. We also aim to educate dermatologists about a disease with high morbidity and assist in its difficult recognition.

Conflict of interest statement

Conflict of Interest: None.

Figures

FIGURE 1
FIGURE 1
Initial clinical lesion, with one - month evolution, in a case of localized cutaneous leishmaniasis. Patient evolved with ulceration and development of a typical ATL cutaneous lesion
FIGURE 2
FIGURE 2
ATL ulcer with elevated borders: evolution of the case after five months.
FIGURE 3
FIGURE 3
Case of cutaneous leishmaniasis with 10 years of evolution. An intense destruction of the nasal septum can be observed. This case represents a severe unusual clinical lesion, however it illustrates the potential severity of mucosal leishmaniasis.
FIGURE 4
FIGURE 4
Montenegro skin test: intradermal application of a solution containing antigenic preparation of promastigote forms of Leishmania. The result should be evaluated within 48 hours with a ballpoint pen, being positive if the papule formed is equal or greater than 5mm
FIGURE 5
FIGURE 5
Indirect search for antibodies. Positive result with fluorescence of the promastigote forms of Leishmania
FIGURE 6
FIGURE 6
Histopatholo gical exam showing several amastigote forms in a case of cutaneous leishmaniasis (Giemsa 400x)
FIGURE 7
FIGURE 7
Histopatholo gical exam showing intense pseudoepitheliomatous hyperplasia (H&E 10x)
FIGURE 8
FIGURE 8
Solid culture medium for Leishmania - Neal, Novy, Nicolle (NNN). The sample material aspirated from the border of the cutaneous ulcer can be inoculated in this medium
FIGURE 9
FIGURE 9
In vivo culture: C57BL/6 strain mouse, Mus musculus species, adult female infected subcutaneously on the right paw with 3.57 x 106 promastigotes of Leishmania (L.)amazonensis, in the metacyclic phase.
FIGURE 10
FIGURE 10
Collection technique of an imprint in paper filter of material from incisional biopsy. The collected material can be easily stored, sent for DNA extraction and polymerase chain reaction
FIGURE 11
FIGURE 11
Agarose gel print of PCR amplified material showing positivity forLeishmania spp. Sample collected from a lesion, in a case of mucosal leishmaniasis, by paper filter imprinting (6) and nasal swab (7). Demonstration of positivity on incisional biopsy sample, in a case of cutaneous leishmaniasis (9). Positive control (10). Negative control (11). 100 bp molecular marker (12). Exam performed at the Dermatology Service Laboratory, HC-FMRP-USP, Ribeirão Preto, SP, Brazil
FIGURE 12
FIGURE 12
10% acrylamide gel electrophoresis after enzymatic digestion of PCR amplified material - PCR-RFLP. Digestion by the enzyme HaeIII in species L. donovani (4); L. (V.) braziliensis (5); L (L.) amazonensis (6) kept in culture. Digestion by the enzyme BsrI in species L. donovani (12); L. (V.) braziliensis(13); L (L.) amazonensis (14) kept in culture. Depicts 50 bp and 100bp molecular markers respectively (7, 8). Exam performed at the Dermatology Service Laboratory, HC-FMRP-USP, Ribeirão Preto, SP, Brazil

References

    1. do Vale ECS, Furtado T. Tegumentary leishmaniasis in Brazil: a historical review related to the origin, expansion and etiology. An Bras Dermatol. 2005;80:421–428.
    1. de Lima EB, Porto C, da Motta JOC, Sampaio RNR. Treatment of American cutaneous leishmaniasis. An Bras Dermatol. 2007;82:111–124.
    1. de Lima MVN, de Oliveira RZ, de Lima AP, Cerino DA, Silveira TGV. American cutaneous leishmaniasis with fatal outcome during pentavalent antimoniate treatment. An Bras Dermatol. 2007;82:269–271.
    1. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica . Manual de Vigilância da Leishmaniose Tegumentar Americana. 2 ed. Brasília: Ministério da Saúde; 2007. 182p
    1. Wise ES, Armstrong MS, Watson J, Lockwood DN. Monitoring toxicity associated with parenteral sodium stibogluconate in the day-case management of returned travellers with New World cutaneous leishmaniasis. PLoS Negl Trop Dis. 2012;6:e1688–e1688.
    1. Lima MI, Arruda VO, Alves EV, de Azevedo AP, Monteiro SG, Pereira SR. Genotoxic effects of the antileishmanial drug Glucantime. Arch Toxicol. 2010;84:227–232.
    1. Sampaio RNR. Leishmaniose Tegumentar Americana: Diagnóstico e Tratamento. In: Lupi O, Cunha PR, editors. Rotinas de Diagnóstico e Tratamento da Sociedade Brasileira de Dermatologia. Rio de Janeiro: AC Farmacêutica; 2012. pp. 379–387.
    1. Zaghi D, Panosian C, Gutierrez MA, Gregson A, Taylor E, Ochoa MT. New World cutaneous leishmaniasis: current challenges in diagnosis and parenteral treatment. J Am Acad Dermatol. 2011;64:587–592.
    1. Goto H, Lindoso JA. Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther. 2010;8:419–433.
    1. Field V, Gautret P, Schlagenhauf P, Burchard GD, Caumes E, Jensenius M, et al. Travel and migration associated infectious diseases morbidity in Europe, 2008. BMC Infect Dis. 2010;10:330–330.
    1. Gil JF, Nasser JR, Cajal SP, Juarez M, Acosta N, Cimino RO, et al. Urban transmission of American cutaneous leishmaniasis in Argentina: spatial analysis study. Am J Trop Med Hyg. 2010;82:433–440.
    1. Weirather JL, Jeronimo SM, Gautam S, Sundar S, Kang M, Kurtz MA, et al. Serial quantitative PCR assay for detection, species discrimination, and quantification of Leishmania spp. in human samples. J Clin Microbiol. 2011;49:3892–3904.
    1. Souza LW, Souza SV, Botelho AC. Comparative analysis of the geographic distribution of the histopathological spectrum and Leishmania species of American cutaneous leishmaniasis in Brazil. An Bras Dermatol. 2012;87:369–374.
    1. Mitropoulos P, Konidas P, Durkin-Konidas M. New World cutaneous leishmaniasis: updated review of current and future diagnosis and treatment. J Am Acad Dermatol. 2010;63:309–322.
    1. Viana AG, Fraga CA, Batista Domingos PL, Bonan PR. Evaluation of myofibroblasts and its association with TGF-ß and IFN-γ lesions of patients with American tegumentary leishmaniasis. An Bras Dermatol. 2012;87:545–549.
    1. Gontijo B, Carvalho MLR. Leishmaniose tegumentar americana. Rev Inst Med Trop. 2003;36:71–80.
    1. Gomes CM, Morais OO, Leite AS, Soares KA, Motta Jde O, Sampaio RN. Periungual leishmaniasis. An Bras Dermatol. 2012;87:148–149.
    1. Cannavò SP, Vaccaro M, Guarneri F. Leishmaniasis recidiva cutis. Int J Dermatol. 2000;39:205–206.
    1. Machado PR, Rosa ME, Costa D, Mignac M, Silva JS, Schriefer A, et al. Reappraisal of the immunopathogenesis of disseminated leishmaniasis: in situ and systemic immune response. Trans R Soc Trop Med Hyg. 2011;105:438–444.
    1. Barral A, Costa JM, Bittencourt AL, Barral-Netto M, Carvalho EM. Polar and subpolar diffuse cutaneous leishmaniasis in Brazil: clinical and immunopathologic aspects. Int J Dermatol. 1995;34:474–479.
    1. França-Costa J, Wanderley JL, Deolindo P, Zarattini JB, Costa J, Soong L, et al. Exposure of phosphatidylserine on Leishmania amazonensis isolates is associated with diffuse cutaneous leishmaniasis and parasite infectivity. PLoS One. 2012;7:e36595–e36595.
    1. Guimarães LH, Machado PR, Lago EL, Morgan DJ, Schriefer A, Bacellar O, et al. Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil. Trans R Soc Trop Med Hyg. 2009;103:712–715.
    1. Silveira FT, Lainson R, Corbett CE. Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz. 2005;100:525–534.
    1. Castellucci L, Menezes E, Oliveira J, Magalhaes A, Guimaraes LH, Lessa M, et al. IL6 -174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis. 2006;194:519–527.
    1. Motta AC, Lopes MA, Ito FA, Carlos-Bregni R, de Almeida OP, Roselino AM. Oral leishmaniasis: a clinicopathological study of 11 cases. Oral Dis. 2007;13:335–340.
    1. Medeiros AR, Silva WA, Jr, Roselino AM. DNA sequencing confirms the involvement of Leishmania (L.) amazonensis in American tegumentary leishmaniasis in the state of São Paulo, Brazil. Clinics (Sao Paulo) 2008;63:451–456.
    1. Ben Salah A, Ben Alaya Bouafif N, Chlif S, Gharbi A, Bel Haj Hamida N, Zaatour A, et al. Risk factors of leishmanin-skin test positivity in transmission of Leishmania infantum in the center of Tunisia. Arch Inst Pasteur Tunis. 2003;80:17–27.
    1. Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, et al. The relationship between leishmaniasis and AIDS: the second 10 years. Microbiol Rev. 2008;21:334–359. table of contentes.
    1. Castellano LR, Llaguno M, Silva MV, Machado JR, Correia D, Silva-Vergara ML, et al. Immunophenotyping of circulating T cells in a mucosal leishmaniasis patient coinfected with HIV. Rev Soc Bras Med Trop. 2011;44:520–521.
    1. Roselino AM, Chociay MF, Costa RS, Machado AA, Figueiredo JF. (L.) chagasi in AIDS and visceral leishmaniasis co-infection. Rev Inst Med Trop Sao Paulo. 2008;50:251–254.
    1. Bari AU. Clinical spectrum of cutaneous leishmaniasis: an overview from Pakistan. Dermatol Online J. 2012;18:4–4.
    1. Pereira MG. Epidemiologia: Teoria e Prática. 3 ed. Guanabara Koogan: Rio de Janeiro; 2000.
    1. Garcia AL, Kindt A, Quispe-Tintaya KW, Bermudez H, Llanos A, Arevalo J, et al. American tegumentary leishmaniasis: antigen-gene polymorphism, taxonomy and clinical pleomorphism. Infect Genet Evol. 2005;5:109–116.
    1. Reis Lde C, Brito ME, Almeida EL, Félix SM, Medeiros AC, Silva CJ, et al. Clinical, epidemiological and laboratory aspects of patients with American cutaneous leishmaniasis in the State of Pernambuco. Rev Soc Bras Med Trop. 2008;41:439–443.
    1. Boggild AK, Ramos AP, Espinosa D, Valencia BM, Veland N, Miranda-Verastegui C, et al. Clinical and demographic stratification of test performance: a pooled analysis of five laboratory diagnostic methods for American cutaneous leishmaniasis. Am J Trop Med Hyg. 2010;83:345–350.
    1. Pineda JA, Macías J, Morillas F, Fernández-Ochoa J, Cara J, de la Rosa R, et al. False-positive results of leishmanin skin test due to phenol-containing diluent. Trans R Soc Trop Med Hyg. 2001;95:173–174.
    1. Fagundes A, Antônio L, Schubach A, Marzochi KB, Fagundes A. Comparison between in vivo measurement of the Montenegro skin test and paper recording. Int J Dermatol. 2012;51:618–619.
    1. Szargiki R, Castro EA, Luz E, Kowalthuk W, Machado AM, Thomaz-Soccol V. Comparison of serological and parasitological methods for cutaneous leishmaniasis diagnosis in the state of Paraná, Brazil. Braz J Infect Dis. 2009;13:47–52.
    1. Pomares C, Despierres L, del Giudice P, Delaunay P, Michel G, Ferrua B, et al. Western blot analysis as an aid for the diagnosis of cutaneous leishmaniasis due to Leishmania major. Trans R Soc Trop Med Hyg. 2012 Jul;106:452–454.
    1. Zeyrek FY, Korkmaz M, Ozbel Y. Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL Is highly endemic. Clin Vaccine Immunol. 2007;14:1409–1415.
    1. Romero GA, de la Glória Orge Orge M, de Farias Guerra MV, Paes MG, de Oliveira Macêdo V, de Carvalho EM. Antibody response in patients with cutaneous leishmaniasis infected by Leishmania (Viannia) braziliensis or Leishmania (Viannia) guyanensis in Brazil. Acta Trop. 2005;93:49–56.
    1. Daneshbod Y, Oryan A, Davarmanesh M, Shirian S, Negahban S, Aledavood A, et al. Clinical, histopathologic, and cytologic diagnosis of mucosal leishmaniasis and literature review. Arch Pathol Lab Med. 2011;135:478–482.
    1. Hosseinzadeh M, Omidifar N, Lohrasb MH. Use of fine needle aspiration cytology in the diagnosis of cutaneous leishmaniasis: a comparison with the conventional scraping method. Trop Doct. 2012;42:112–113.
    1. Ameen M. Cutaneous leishmaniasis: advances in disease pathogenesis, diagnostics and therapeutics. Clin Exp Dermatol. 2010;35:699–705.
    1. Lunedo SN, Thomaz-Soccol V, de Castro EA, Telles JE. Immunocytochemical and immunohistochemical methods as auxiliary techniques for histopathological diagnosis of cutaneous leishmaniasis. Acta Histochem. 2012;114:252–258.
    1. Herwaldt BL. Leishmaniasis. Lancet. 1999;354:1191–1199.
    1. Viana AG, Domingos PL, Kaminagakura E, Botelho AC, Martelli H, Jr, Bonan PR. Immunohistochemical profile of cytokeratins in pseudoepitheliomatous hyperplasia of cutaneous leishmaniasis. Int J Dermatol. 2011;50:1470–1474.
    1. Romero GA, Sampaio RN, Macedo Vde O, Marsden PD. Sensitivity of a vacuum aspiratory culture technique for diagnosis of localized cutaneous leishmaniasis in an endemic area of Leishmania (Viannia) braziliensis transmission. Mem Inst Oswaldo Cruz. 1999;94:505–508.
    1. Pavli A, Maltezou HC. Leishmaniasis, an emerging infection in travelers. Int J Infect Dis. 2010;14:e1032–e1039.
    1. Boggild AK, Miranda-Verastegui C, Espinosa D, Arevalo J, Adaui V, Tulliano G, et al. Evaluation of a microculture method for isolation of Leishmania parasites from cutaneous lesions of patients in Peru. J Clin Microbiol. 2007;45:3680–3684.
    1. Boggild AK, Miranda-Verastegui C, Espinosa D, Arevalo J, Martinez-Medina D, Llanos-Cuentas A, et al. Optimization of microculture and evaluation of miniculture for the isolation of Leishmania parasites from cutaneous lesions in Peru. Am J Trop Med Hyg. 2008;79:847–852.
    1. Allahverdiyev AM, Uzun S, Bagirova M, Durdu M, Memisoglu HR. A sensitive new microculture method for diagnosis of cutaneous leishmaniasis. Am J Trop Med Hyg. 2004;70:294–297.
    1. Silva JG, Silva TM, Peloso Ede F, Machado-Coelho GL, Mayrink W, Ariosa MC, et al. Comparison among three polymerase chain reaction assays on detection of DNA from Leishmania in biological samples from patients with American cutaneous leishmaniasis. Rev Soc Bras Med Trop. 2012;45:257–259.
    1. Roselino AM. Molecular biology in tropical dermatoses. An Bras Dermatol. 2008;83:187–203.
    1. Miranda A, Saldaña A, González K, Paz H, Santamaría G, Samudio F, et al. Evaluation of PCR for cutaneous leishmaniasis diagnosis and species identification using filter paper samples in Panama, Central America. Trans R Soc Trop Med Hyg. 2012;106:544–548.
    1. Graça GC, Volpini AC, Romero GA, Oliveira MP, Neto, Hueb M, Porrozzi R, et al. Development and validation of PCR-based assays for diagnosis of American cutaneous leishmaniasis and identification of the parasite species. Mem Inst Oswaldo Cruz. 2012;107:664–674.
    1. Kim OM, de Paula N, Roselino AM. Métodos diagnósticos em biologia molecular aplicada a dermatoses tropicais. In: Lupi O, Cunha PR, editors. Rotinas de Diagnóstico e Tratamento da Sociedade Brasileira de Dermatologia. Rio de Janeiro: AC Farmacêutica; 2012. pp. 463–471.
    1. Yehia L, Adib-Houreih M, Raslan WF, Kibbi AG, Loya A, Firooz A, et al. Molecular diagnosis of cutaneous leishmaniasis and species identification: analysis of 122 biopsies with varied parasite index. J Cutan Pathol. 2012;39:347–355.
    1. Al-Jawabreh A, Schoenian G, Hamarsheh O, Presber W. Clinical diagnosis of cutaneous leishmaniasis: a comparison study between standardized graded direct microscopy and ITS1-PCR of giemsa-stained smears. Acta Trop. 2006;99:55–61.
    1. Schönian G, Kuhls K, Mauricio IL. Parasitology. Molecular approaches for a better understanding of the epidemiology and population genetics of Leishmania. Parasitology. 2011;138:405–425.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera